ATE311183T1 - Enalaprilmaleat enthaltende, stabile, feste arzneimittel - Google Patents
Enalaprilmaleat enthaltende, stabile, feste arzneimittelInfo
- Publication number
- ATE311183T1 ATE311183T1 AT00920968T AT00920968T ATE311183T1 AT E311183 T1 ATE311183 T1 AT E311183T1 AT 00920968 T AT00920968 T AT 00920968T AT 00920968 T AT00920968 T AT 00920968T AT E311183 T1 ATE311183 T1 AT E311183T1
- Authority
- AT
- Austria
- Prior art keywords
- stable
- enalaprilmaleate
- products containing
- medicinal products
- solid medicinal
- Prior art date
Links
- 108010061435 Enalapril Proteins 0.000 title abstract 2
- 229960000309 enalapril maleate Drugs 0.000 title abstract 2
- OYFJQPXVCSSHAI-QFPUQLAESA-N enalapril maleate Chemical compound OC(=O)\C=C/C(O)=O.C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(O)=O)CC1=CC=CC=C1 OYFJQPXVCSSHAI-QFPUQLAESA-N 0.000 title abstract 2
- 239000007787 solid Substances 0.000 title abstract 2
- 229940126601 medicinal product Drugs 0.000 title 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 239000011976 maleic acid Substances 0.000 abstract 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid group Chemical group C(\C=C/C(=O)O)(=O)O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/556—Angiotensin converting enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Vascular Medicine (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/304,413 US6296871B1 (en) | 1998-04-12 | 1999-05-03 | Stable solid pharmaceutical compositions containing enalapril maleate |
| PCT/IB2000/000569 WO2000066116A2 (en) | 1999-05-03 | 2000-05-03 | Stable solid pharmaceutical compositions containing enalapril maleate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE311183T1 true ATE311183T1 (de) | 2005-12-15 |
Family
ID=23176416
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00920968T ATE311183T1 (de) | 1999-05-03 | 2000-05-03 | Enalaprilmaleat enthaltende, stabile, feste arzneimittel |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1178793B1 (de) |
| AT (1) | ATE311183T1 (de) |
| AU (1) | AU4137300A (de) |
| DE (1) | DE60024439D1 (de) |
| MY (1) | MY121470A (de) |
| WO (1) | WO2000066116A2 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001019348A1 (en) * | 1999-09-17 | 2001-03-22 | Mylan Pharmaceuticals Inc. | Stabilization of enalapril maleate with maleic acid |
| WO2012085249A2 (en) * | 2010-12-24 | 2012-06-28 | Krka, D.D., Novo Mesto | Homogenous pharmaceutical oral dosage forms comprising lercanidipine and enalapril or their pharmaceutically acceptable salts |
| PH12013501442B1 (en) | 2011-01-07 | 2018-04-20 | Novartis Ag | Immunosuppressant formulations |
| CN104984317A (zh) * | 2015-07-20 | 2015-10-21 | 广州帝奇医药技术有限公司 | 含有依那普利的药物组合物及其制备方法 |
| CL2024001316A1 (es) * | 2024-04-29 | 2025-04-25 | Laboratorios Andromaco S A | Composición farmacéutica que comprende enalapril maleato, uso y proceso de preparación. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4743450A (en) * | 1987-02-24 | 1988-05-10 | Warner-Lambert Company | Stabilized compositions |
| CA2128199C (en) * | 1994-07-15 | 1997-02-04 | Bernard Charles Sherman | Stable solid pharmaceutical compositions containing enalapril maleate |
| IT1282650B1 (it) * | 1996-02-19 | 1998-03-31 | Jagotec Ag | Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici |
| HU222497B1 (hu) * | 1996-12-18 | 2003-07-28 | Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. | Enalapril-maleátot tartalmazó stabilizált gyógyszerkészítmény és eljárás előállítására |
-
2000
- 2000-05-02 MY MYPI20001881A patent/MY121470A/en unknown
- 2000-05-03 AU AU41373/00A patent/AU4137300A/en not_active Abandoned
- 2000-05-03 WO PCT/IB2000/000569 patent/WO2000066116A2/en not_active Ceased
- 2000-05-03 EP EP00920968A patent/EP1178793B1/de not_active Expired - Lifetime
- 2000-05-03 AT AT00920968T patent/ATE311183T1/de not_active IP Right Cessation
- 2000-05-03 DE DE60024439T patent/DE60024439D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1178793A2 (de) | 2002-02-13 |
| WO2000066116A2 (en) | 2000-11-09 |
| AU4137300A (en) | 2000-11-17 |
| EP1178793B1 (de) | 2005-11-30 |
| DE60024439D1 (de) | 2006-01-05 |
| WO2000066116A3 (en) | 2001-06-28 |
| MY121470A (en) | 2006-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2003047519A3 (en) | 'compressed annular tablet with molded triturate tablet for oral and intraoral' | |
| CA2258095A1 (en) | Tetrahydrolipstatin containing compositions | |
| ATE215816T1 (de) | Feste oral anzuwendende arzeneiform | |
| HUP0302319A3 (en) | Pharmaceutical composition for oral administration of active ingredient | |
| HUP0302131A2 (hu) | Gyógyászati tramadolsók, ezeket tartalmazó gyógyszerkészítmények | |
| CA2385890A1 (en) | Controlled release compositions comprising nimesulide | |
| NZ507566A (en) | Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants | |
| HUP0004383A2 (hu) | Hatóanyagként klodronátot és vivőanyagként szilíciumozott mikrokristályos cellulózt tartalmazó gyógyszerészeti készítmény | |
| HUP0303891A3 (en) | Pharmaceutically active piridine derivatives, process for their preparation and pharmaceutical compositions containing them | |
| WO2001041770A3 (en) | Nanoparticulate eplerenone compositions | |
| DE3678661D1 (de) | Arzneimittel mit langsamer wirkstofffreisetzung. | |
| HUP0203312A3 (en) | Pharmaceutically active sulfonamide derivatives, process for their preparation, and pharmaceutical compositions and their use | |
| WO1998009597A3 (en) | Cushioning beads and tablet comprising the same capable of forming a suspension | |
| MX9804008A (es) | Formulaciones farmaceuticas. | |
| CA2326517A1 (en) | New galenic preparations of meloxicam for oral administration | |
| CA2258918A1 (en) | Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof | |
| CA2382387A1 (en) | Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and/or congestive heart failure | |
| WO2007009806A3 (en) | Solid dosage formulations of narcotic drugs having improved buccal adsorption | |
| CA2445519A1 (en) | Method for manufacturing a low dose pharmaceutical composition | |
| EP0749308A1 (de) | Filmbeschichtete tablette, die paracetamol und domperidone enthält | |
| WO2008142572A3 (en) | Controlled release tablet formulation containing magnesium aluminometasilicate | |
| WO2001041742A3 (en) | Antiviral medication | |
| WO2002045686A3 (en) | Pharmaceutical paste comprising an acid-labile active ingredient | |
| WO2002024203A3 (en) | Controlled release formulations for oral administration | |
| AR011919A1 (es) | FORMULACIoN EN COMPRIMIDOS O CÁPSULAS PARA TRAGAR DE PARACETAMOL (N-ACETIL-P-AMINOFENOL) Y PROCEDIMIENTO PARA PREPARARLA |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |